These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1925368)

  • 1. [Therapeutic trial. Principles of interpretation].
    Bouvenot G; Eschwege E
    Rev Prat; 1991 Sep; 41(19):1853-7. PubMed ID: 1925368
    [No Abstract]   [Full Text] [Related]  

  • 2. [Roaming through methodology. XVII. The placebo effect].
    de Craen AJ
    Ned Tijdschr Geneeskd; 2000 Feb; 144(7):322-4. PubMed ID: 10707743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trend toward noninferiority trials may mean more difficult interpretation of trial results.
    Tuma RS
    J Natl Cancer Inst; 2007 Dec; 99(23):1746-8. PubMed ID: 18042926
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trials and statistical analyses: what should dermatologists look for in a report?
    Alosh M; Fritsch K; Soukup M; Wilkin J
    Dermatol Ther; 2009; 22(3):199-203. PubMed ID: 19453343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [How to improve the quality of clinical trials].
    Galende I; Sacristán JA; Soto J
    Med Clin (Barc); 1994 Apr; 102(12):465-70. PubMed ID: 8207997
    [No Abstract]   [Full Text] [Related]  

  • 6. [The clinical trial for only one patient. Justification, methodology and bioethical remarks].
    Cabello López JB; Abraira V; Gómez García J
    Med Clin (Barc); 1997 Nov; 109(15):592-8. PubMed ID: 9441196
    [No Abstract]   [Full Text] [Related]  

  • 7. Committee for Medicinal Products for Human Use (CHMP) guideline on the choice of the non-inferiority margin.
    ; ;
    Stat Med; 2006 May; 25(10):1628-38. PubMed ID: 16639773
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluating statistics in clinical trials: making the unintelligible intelligible.
    Gilmore SJ
    Australas J Dermatol; 2008 Nov; 49(4):177-84; quiz 185-6. PubMed ID: 18855776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for clinical trials in melasma. Pigmentation Disorders Academy.
    Pandya A; Berneburg M; Ortonne JP; Picardo M
    Br J Dermatol; 2006 Dec; 156 Suppl 1():21-8. PubMed ID: 17176301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study design: statistical and methodologic considerations.
    Rubenfeld GD
    Respir Care; 1995 Sep; 40(9):980-6. PubMed ID: 10152244
    [No Abstract]   [Full Text] [Related]  

  • 11. Standard versus adaptive monitoring procedures: A commentary.
    Fleming TR
    Stat Med; 2006 Oct; 25(19):3305-12; discussion 3313-4, 3326-47. PubMed ID: 16850447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five easy pieces on evidence-based medicine (4).
    Kalso E; Edwards J; McQuay HJ; Moore RA
    Eur J Pain; 2002; 6(1):89-93. PubMed ID: 11888232
    [No Abstract]   [Full Text] [Related]  

  • 13. Data handling in clinical trials: an ongoing debate.
    Jongen PJ
    Mult Scler; 1995; 1 Suppl 1():S60-3. PubMed ID: 9345402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
    Khan OA; Tselis A; Boster A
    Neurology; 2009 Jun; 72(24):2134; author reply 2134-5. PubMed ID: 19528523
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomization as a basis for inference in noninferiority trials.
    Wiens BL
    Pharm Stat; 2006; 5(4):265-71. PubMed ID: 17128425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Difficulties in planning in therapeutic comparisons].
    Van de Loo J
    Methods Inf Med Suppl; 1976; 9():47-51. PubMed ID: 1078453
    [No Abstract]   [Full Text] [Related]  

  • 17. Interpretation of clinical trial results.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S114-20. PubMed ID: 19007606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we obtain credible estimates of the causal effects of interventions from non-randomized trials (observational studies or so-called quasi-experiments)?
    Dunn G
    Crim Behav Ment Health; 2005; 15(2):123-5. PubMed ID: 16470507
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment duration in acute hepatitis C: the issue is not solved yet.
    Wedemeyer H; Cornberg M; Wiegand J; Manns M
    Hepatology; 2006 Oct; 44(4):1051; author reply 1051-2. PubMed ID: 17006944
    [No Abstract]   [Full Text] [Related]  

  • 20. How to design a clinical trial.
    Curtis BM; Barrett BJ; Parfrey PS
    Methods Mol Med; 2003; 86():475-89. PubMed ID: 12886789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.